Lonza

In News

Lonza hands off capsule business to investment firm Lone Star in $3B deal - Fierce Pharma

Fierce Pharma - Mar 06, 2026

Lonza to sell capsule and health ingredients business to Lone Star for $3.0 billion - Reuters

Reuters - Mar 06, 2026

Lonza Divests Capsules & Health Ingredients Business for $3 Billion - CHEManager

CHEManager - Mar 10, 2026

Lonza and Genetix Biotherapeutics Extend Commercial Manufacturing Agreement for ZYNTEGLO - the-scientist.com

the-scientist.com - Mar 09, 2026

Lonza, Genetix Bio Extend Commercial Mfg. Pact for ZYNTEGLO - Contract Pharma

Contract Pharma - Mar 09, 2026

Lone Star Funds to acquire Lonza’s Capsules & Health Ingredients - Nutrition Insight

Nutrition Insight - Mar 09, 2026

Octane Medical Group Signs Agreement to Acquire Lonza's Personalized Medicine Business - TMX Newsfile

TMX Newsfile - Mar 04, 2026

Lonza to offload capsule and health ingredients biz to Lone Star in $3bn transaction - BioXconomy

BioXconomy - Mar 09, 2026

BRIEF—Lonza and Genetix Biotherapeutics extend deal - The Pharma Letter

The Pharma Letter - Mar 09, 2026

Lone Star agrees to buy Lonza’s Capsules and Health Ingredients division - pehub.com

pehub.com - Mar 09, 2026

Lonza sells capsule and health ingredients unit to UK's Lone Star for $2.2B upfront - Endpoints News

Endpoints News - Mar 06, 2026

Switzerland: Lonza completing transformation to pure-play CDMO with divestment of Capsules & Health Ingredients - Investors in Healthcare

Investors in Healthcare - Mar 09, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment